Stock KLAR KLARIA PHARMA HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Klaria Pharma Holding AB

Equities

KLAR

SE0007280326

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm
Other stock markets
 10:25:57 2024-04-24 am EDT 		5-day change 1st Jan Change
0.289 SEK -1.70% Intraday chart for Klaria Pharma Holding AB +60.11% -37.45%
Feb. 29 Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 29 Klaria Pharma Holding AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Business Summary

Klaria Pharma Holding AB (publ) is a Sweden-based holding company engaged in the biotechnology and medical research industry. Through its group subsidiaries, the Company is active in developing and commercializing therapeutic drugs and treatment methods in the fields of migraine and pain related to cancer based on a patented drug delivery platform in the form of an alginate-based polymer film, which facilitates rapid and reliable transmucosal absorption via a muco-adhesive film. The Company operates Klaria Pharma AB as a wholly owned subsidiary.

Number of employees: 5

Sales per Business

SEK in Million2021Weight2022Weight Delta
Pharmaceutical Drug Development
100.0 %
0 nan % 6 100.0 % -

Sales per region

SEK in Million2021Weight2022Weight Delta
Sweden
100.0 %
0 nan % 6 100.0 % -

Managers

Managers TitleAgeSince
Scott Boyer CEO
 Chief Executive Officer 62 14-12-31
Hans-Peder Richter DFI
 Director of Finance/CFO 75 -
Hans Olivecrona CTO
 Chief Tech/Sci/R&D Officer 66 22-02-28

Members of the board

Members of the board TitleAgeSince
Fredrik Hübinette FOU
 Founder 55 14-12-31
Scott Boyer CEO
 Chief Executive Officer 62 14-12-31
Anders Jacobson BRD
 Director/Board Member 57 21-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 106,500,523 74,061,128 ( 69.54 %) 0 69.54 %

Company contact information

Klaria Pharma Holding AB

Virdings Allé 2

754 50, Uppsala

+46 84 46 42 99

http://www.klaria.com
address Klaria Pharma Holding AB(KLAR)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Ratings for Klaria Pharma Holding AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
KLARIA PHARMA HOLDING AB Stock Klaria Pharma Holding AB
-37.45% 2.89M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.51% 105B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+3.22% 97.5B
ARGENX SE Stock argenx SE
+1.86% 22.19B
BIONTECH SE Stock BioNTech SE
-16.53% 21.33B
GENMAB A/S Stock Genmab A/S
-8.49% 18.68B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.33% 16.6B
BEIGENE, LTD. Stock BeiGene, Ltd.
-20.09% 14.52B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.47% 14.09B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+28.85% 10.99B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. KLAR Stock
  4. Company Klaria Pharma Holding AB